Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...
Analysts think that alopecia areata could represent a $1 billion-plus opportunity, as current treatment relies on corticosteroid drugs, which suppress the immune system, but can have serious side ...